首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Clinical & Experimental Metastasis

Clinical & Experimental Metastasis杂志,由Springer Netherlands出版,于1983年创刊,Bimonthly,出版语言English,ISSN:0262-0898,E-ISSN:1573-7276。

投稿咨询
Clinical & Experimental Metastasis
Clinical & Experimental Metastasis
Clinical & Experimental Metastasis
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.7
CiteScore
7.4
期刊收录
SCI、SCIE

Clinical & Experimental Metastasis(中文译名:《临床和实验性转移》),ISSN:0262-0898,EISSN:1573-7276,是Springer Netherlands出版的国际性学术期刊,创刊于1983年,以Bimonthly形式稳定发行,2026年总发文量约57篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.7,2025年期刊CiteScore为7.4,2025年期刊自引率约2.7%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Clinical & Experimental Metastasis长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约12月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAGERMANY (FED REP GER)、England、Australia、CHINA MAINLAND、Japan、Spain等为核心发文国家与地区;HELMHOLTZ ASSOCIATIONUNIVERSITY OF TEXAS SYSTEM、RUPRECHT KARLS UNIVERSITY HEIDELBERG、FREE UNIVERSITY OF BERLIN、HUMBOLDT UNIVERSITY OF BERLIN、PETER MACCALLUM CANCER CENTER、UNIVERSITY OF MELBOURNE等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 129 / 333

61.4

学科:ONCOLOGY SCIE Q2 151 / 333

54.8

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 130 / 328

60.5

学科:ONCOLOGY SCIE Q2 140 / 328

57.47


中国学者近期发文

1
All-site radiotherapy for metastatic ewing's sarcoma: a short-term analysis of feasibility, response, and safet

Author:Yang, YuanYou; Xie, Lu; Sun, Xin; Xu, Jie; Ren, Gang

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s10585-026-10406-0

2
LINC01996 suppresses non-small cell lung cancer proliferation and metastasis by orchestrating the miR-12115/CNRIP1/Ras signaling axi

Author:Zhang, Yi; Li, Xiaojing; Liu, Shanshan; Xue, Qian; Meng, Peize; Ge, Xiaolu; Zhao, Qingnan; Ma, Haitao

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 2, pp. -. DOI: 10.1007/s10585-026-10399-w

3
A novel multimodal combining radiomics and tumor-stroma ratio (TSR) improves diagnosis of gastric cancer peritoneal metastasi

Author:Zhong, Lin; Lin, Ting; Hou, Dong; Huang, Hongyun; Zhou, Shihai; Lin, Yu; Yu, Yue; Liu, Liangquan; Luo, Jing; Han, Fanghai; Xie, Lang

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 2, pp. -. DOI: 10.1007/s10585-026-10393-2

4
The clinical trial landscape of colorectal cancer liver metastases: profile analysis and target predictio

Author:Li, Ming; Kai, Jinyan; Xu, Yuchentian; Zhu, Shuai; Chen, Zhijun; Zhao, Huiqing; Zhu, Weixiong

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 1, pp. -. DOI: 10.1007/s10585-026-10392-3

5
Predictive significance of anterior and posterior minimal extrathyroidal extension for central lymph node metastasis in cN0 papillary thyroid carcinom

Author:Zhao, Qi; Zhang, Yuyang; Hua, Rui; Lv, Bin; Liu, Nan

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 1, pp. -. DOI: 10.1007/s10585-025-10388-5

6
Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectini

Author:Yang, Xi; Chu, Xiao; Ye, Ruiting; Ni, Jianjiao; Zeng, Ya; Zhou, Yue; Xia, Qing; Wang, Shengping; Li, Qiao; Liu, Shuai; Zhu, Zhengfei; Chu, Li

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 4, pp. -. DOI: 10.1007/s10585-025-10351-4

7
Deep learning MRI-based radiomic models for predicting recurrence in locally advanced nasopharyngeal carcinoma after neoadjuvant chemoradiotherapy: a multi-center stud

Author:Hu, Chunmiao; Xu, Congrui; Chen, Jiaxin; Huang, Yiling; Meng, Qingcheng; Lin, Zhian; Huang, Xinming; Chen, Li

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10349-y

8
Interplay of GPC3, Hsa-miR-135b-3p, and FTLP3 in lung cancer metastasi

Author:Yang, Lijun; Li, Jiping

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10340-7

9
TEAD4 promoted proliferation and metastasis of gallbladder cancer by regulation of TMPRSS

Author:Lin, Conglin; Wang, Congren; Li, Mingzhu; Cai, Zhibing

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10339-0

10
Ras-proximate-1 (RAP1): a prognosis and therapeutic target in the metastatic spread of breast cance

Author:Liang, Hongyi; Yin, Guoliang; Feng, Dandan; Shi, Guangxi; Chen, Hanhan; Liu, Xiaofei; Li, Jingwei

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10342-5


在线咨询

Clinical & Experimental Metastasis

国际简称:CLIN EXP METASTAS参考译名:临床和实验性转移

年发文量:57 CiteScore:7.4 是否预警:否 Gold OA文章占比:46.75% 研究类文章占比:75.44%

杂志社联系方式:SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ

Clinical & Experimental Metastasis